Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular basis of restenosis and drug-eluting stents.

× No keyword cloud information.

120 in total

1. Regulation of vascular smooth muscle cell proliferation by nuclear orphan receptor Nur77.

Authors: Liyue Wang; Fan Gong; Xiaoyan Dong; Wei Zhou; Qiutang Zeng
Journal: Mol Cell Biochem Date: 2010-04-22 Impact factor: 3.396

2. Five factors and three characteristics of coronary in-stent restenosis.

Authors: Nobuaki Suzuki
Journal: J Thorac Dis Date: 2015-12 Impact factor: 2.895

3. TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients.

Authors: Shao Liang; Ma Aiqun; Li Jiwu; Zhang Ping
Journal: Immunol Res Date: 2016-04 Impact factor: 2.829

4. The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation.

Authors: Takashi Nomiyama; Takafumi Nakamachi; Florence Gizard; Elizabeth B Heywood; Karrie L Jones; Naganari Ohkura; Ryuzo Kawamori; Orla M Conneely; Dennis Bruemmer
Journal: J Biol Chem Date: 2006-08-31 Impact factor: 5.157

5. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.

Authors: Taito Masawa; Shichiro Abe; Shigeru Toyoda; Masashi Sakuma; Takahisa Nasuno; Michiya Kageyama; Michiaki Tokura; Satoshi Koizumi; Isao Taguchi; Teruo Inoue
Journal: Heart Vessels Date: 2015-08-14 Impact factor: 2.037

10. Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations.

Authors: Chunhua Fu; Peng Yu; Ming Tao; Tushar Gupta; Lyle L Moldawer; Scott A Berceli; Zhihua Jiang
Journal: Arterioscler Thromb Vasc Biol Date: 2012-08-16 Impact factor: 8.311

Molecular basis of restenosis and drug-eluting stents.

1. Regulation of vascular smooth muscle cell proliferation by nuclear orphan receptor Nur77.

2. Five factors and three characteristics of coronary in-stent restenosis.

3. TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients.

4. The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation.

5. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.

Review 6. Percutaneous coronary interventions with drug eluting stents for diabetic patients.

7. Coronary stenting: A matter of revascularization.

8. MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation.

9. Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.

10. Monocyte chemoattractant protein-1/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations.